| Literature DB >> 29686620 |
Joanna Wdowczyk1, Danuta Makowiec2, Marcin Gruchała1, Dorota Wejer3, Zbigniew R Struzik4,5.
Abstract
It is commonly believed that higher values of heart rate variability (HRV) indices account for better organization of the network of feedback reflexes driving an organism's response to actual bodily needs. In order to evaluate this organization in heart transplant (HTX) recipients, 58 nocturnal Holter signals of 14 HTX patients were analyzed. Their dynamical properties were evaluated by short-term HRV indices and measures grounded on entropy. Estimates grouped according to the patients' clinical progress: free of complications versus with complications, and arranged in order of the length of time since the HTX, lead us to the conclusion that higher HRV is associated with a worse outcome for HTX patients. Moreover, short-term HRV indices that are constant, rather than increasing over time, serve well in the prognosis of the future state of a HTX patient. These findings suggest that increases observed in HRV indices are related to erratic rhythms resulting from remodeling of the cardiac tissue (including heterogeneous innervation) in long-term HTX patients. Therefore, we hypothesize that dynamical landscape markers (entropy and fragmentation measures together with the short-term HRV indices) can serve as a tool in the exploration of the genesis of (non-respiratory sinus) arrhythmia.Entities:
Keywords: autonomic nervous system; entropic measures; erratic rhythm; heart rate fragmentation; heart rate variability; heart transplant patients
Year: 2018 PMID: 29686620 PMCID: PMC5900061 DOI: 10.3389/fphys.2018.00274
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Patient demographic data.
| M | 65 | 2008/ | CAD | 0 | 1 | 1 | 1 | 1 | 1 | 60 | Survival | |||
| bicav | ||||||||||||||
| M | 47 | 2009/ | CAD | 1 | 1 | 1 | 1 | 0 | 0 | 45 | Death | |||
| bicav | ||||||||||||||
| M | 59 | 2011/ | CAD | 0 | 1 | 1 | 0 | 0 | 1 | 65 | Survival | |||
| bicav | ||||||||||||||
| F | 36 | 2009/ | myocarditis | 0 | 1 | 0 | 1 | 0 | 0 | 65 | Survival | |||
| biatr | ||||||||||||||
| F | 55 | 2010/ | DCM | 0 | 1 | 1 | 0 | 0 | 0 | 65 | Survival | |||
| bicav | ||||||||||||||
| M | 33 | 2013/ | DCM | 0 | 1 | 1 | 0 | 0 | 1 | 60 | Survival | |||
| bicav | ||||||||||||||
| F | 57 | 2009/ | CAD | 1 | 1 | 1 | 1 | 0 | 0 | 60 | Death | |||
| biatr | ||||||||||||||
| M | 51 | 2010/ | DCM | 0 | 1 | 1 | 0 | 1 | 0 | 60 | Survival | |||
| bicav | ||||||||||||||
| M | 52 | 2011/ | CAD | 0 | 0 | 0 | 0 | 0 | 0 | 65 | Survival | |||
| bicav | ||||||||||||||
| M | 51 | 2008/ | CAD | 0 | 1 | 0 | 0 | 0 | 0 | 65 | Survival | |||
| biatr | ||||||||||||||
| M | 55 | 2009/ | CAD | 0 | 0 | 0 | 0 | 0 | 0 | 60 | Survival | |||
| biatr | ||||||||||||||
| M | 49 | 2012/ | DCM | 0 | 1 | 0 | 0 | 0 | 0 | 57 | Survival | |||
| bicav | ||||||||||||||
| M | 24 | 2010/ | DCM | 0 | 0 | 0 | 0 | 0 | 0 | 65 | Survival | |||
| bicav | ||||||||||||||
| M | 61 | 2009/ | CAD | 0 | 0 | 0 | 0 | 0 | 0 | 60 | Survival | |||
| biatr | ||||||||||||||
CAD, coronary artery disease; DCM - dilated cardiomyopathy; HT, hypertension; DM, diabetes mellitus; ChRF, chronic renal failure; 2R, graft rejection; CMV, cytomegalovirus infection; FI, fungal infection; bicav, bicaval heart transplant; biatr, biatrial heart transplant. The bold type indicates diseases discriminative for the NF group: HTX with complications.
Figure 1Illustrations of the nomenclature and concepts used. The differences δRR are calculated for the numbered RR-intervals extracted from the ECG recording. A positive difference is encoded as d; a negative difference is encoded as a. A signal δRR is represented as signals of symbols d and a.
Figure 2Table of HRV indices: standard and new ones, considered in the paper.
Descriptive statistics and linear regression analysis for typical HRV indices.
| HR | 85.4 [75.6, 93.9] | 79.6 [70.4, 86.4] | 60.6 [57.8, 67.8] | |
| RR | 703 [641, 798] | 757 [695, 862] | 963 [892, 1,051] | |
| SDNN | 29.6 [21.7, 45.9] | 29.0 [21.4, 54.8] | 0.912 | 73 [61, 86] |
| 8.31 [7.45, 8.95] | 10.9 [7.91, 21.0] | 25 [21, 37] | ||
| 1.22 [0.37, 2.27] | 6.31 [0.89, 16.5] | 40 [29, 54] | ||
| 0.025 [0.001, 0.064] | 0.083 [0.036, 2.05] | 3.6 [2.1, 13] | ||
| VLF | 736 [329, 1345] | 567 [320, 1332] | 0.825 | 4,575 [3127, 7253] |
| LF | 2.8 [1.2, 7.3] | 6.63 [3.07, 61.0] | 477 [317, 717] | |
| 13.0 [8.6, 17.2] | 27.03 [10.2, 101.9] | 207 [137, 364] | ||
| HR | −0.43 ± 1.0 (−0.09, 0.679) | −1.47 ± 0.91 (−0.27, 0.117) | 0.451 | |
| RR | 4.7 ± 9.6 (0.10, 0.629) | 15.0 ± 10.2 (0.25, 0.150) | 0.467 | |
| SDNN | 1.68 ± 1.50 (0.23, 0.274) | |||
| 0.03 ± 0.12 (0.05, 0.790) | ||||
| 0.110 ± 0.179 (0.13, 0.545) | ||||
| −0.002 ± 0.017(0.00, 0.924) | ||||
| VLF | 34.3 ± 102 (0.07, 0.738) | 291 ± 188 (0.26, 0.131) | 0.258 | |
| LF | 0.39 ± 0.72 (0.12, 0.587) | |||
| −0.19 ± 0.72 (0.05, 0.799) | ||||
(a) Difference between groups by one-way ANOVA on ranks (normality failed) results: medians [25%, 75%], and p-value for the difference between groups.
(b) Linear regression estimates with respect to age: linear regression coefficient ± StdErr (R, p-value: of the test H.
Figure 3The probability density (in %, log-scale) of a pair of events in the case of healthy sexagenarians (top-left), HTX patients free of complications (top-right), and with complication (bottom-left). Note that the scales are different. Finally, the difference between density of the groups NF and F is shown (bottom-right).
Descriptive statistics and linear regression analysis for entropic measures.
| 3.80 [3.42, 3.97] | 4.60 [3.90, 5.51] | 7.32 [6.61, 7.89] | ||
| 2.63 [2.44, 2.80] | 3.20 [2.64, 3.90] | 5.02 [4.53, 5.69] | ||
| 1.38 [1.29, 1.47] | 1.67 [1.37, 2.11] | 2.53 [2.31, 2.90] | ||
| 1.25 [1.11, 1.32] | 1.51 [1.27, 1.83] | 2.49 [2.24, 2.72] | ||
| 0.10 [0.07, 0.14] | 0.13 [0.08, 0.21] | 0.195 | 0.24 [0.17, 0.45] | |
| 0.007 ± 0.04 (0.04, 0.849) | ||||
| 0.011 ± 0.03 (0.08, 0.689) | ||||
| 0.008 ± 0.013 (0.13, 0.553) | ||||
| 0.003 ± 0.014 (0.04, 0.830) | ||||
| 0.006 ± 0.005 (0.27, 0.196) | ||||
(a) Difference between groups by one-way ANOVA on ranks (normality failed) results: medians [25%, 75%], and p-value for the difference between groups.
(b) Linear regression estimates for age: linear regression coefficient ± StdErr (R, p-value of the test H.
Figure 4Time runs of the entropic measures estimated for RR-increments of individuals from HTX groups. Blue marks and curves refer to the F group of patients. Red notation is used for the NF patients. The bold curves represent the best linear regression approximation to the group data. The line is dashed if the hypothesis of the zero regression coefficient cannot be rejected. For both lines, R2 correlation coefficients are shown. Points corresponding to the same patient are connected by faded lines.
Descriptive statistics and linear regression analysis for dynamical patterns indices.
| 2.84 [1.7, 4.3] | 5.3 [2.2, 8.8] | 17.1 [14.9, 18.5] | ||
| 2.29 [1.8, 3.85] | 4.9 [2.5, 7.7] | 16.6 [12.2, 19.2] | ||
| 0.10 [0.03, 0.16] | 0.36 [0.06, 1.2] | 4.54 [3.17, 6.13] | ||
| 0.07 [0.03, 0.23] | 0.33 [0.06, 0.75] | 4.23 [2.61, 6.62] | ||
| 15.6 [14.4, 16.7] | 17.3 [15.6, 21.5] | 19.7 [16.8, 24.0] | ||
| 16.1 [15.1, 17.0] | 17.5 [16.0, 21.6] | 19.1 [16.2, 23.3] | ||
| 7.32 [5.95, 8.41] | 7.94 [6.60, 11.1] | 0.060 | 6.45 [5.22, 1.01] | |
| 6.84 [5.65, 7.79] | 8.14 [6.57, 10.6] | 6.26 [4.89, 10.5] | ||
| −0.01 ± 0.15 (0.00, 0.948) | ||||
| −0.08 ± 0.13 (0.13, 0.528) | ||||
| −0.01 ± 0.02 (0.13, 0.557) | 0.07 ± 0.06 (0.21, 0.240) | 0.222 | ||
| −0.02 ± 0.02 (0.23, 0.272) | ||||
| 0.20 ± 0.13 (0.32, 0.131) | 0.160 | |||
| 0.26 ± 0.15 (0.34, 0.099) | 0.299 | |||
| 0.16 ± 0.14 (0.23, 0.271) | 0.42 ± 0.28 (0.25, 0.144) | 0.440 | ||
| 0.11 ± 0.11 (0.21, 0.329) | 0.27 ± 0.28 (0.17, 0.344) | 0.626 | ||
(a): Difference between groups by one-way ANOVA on ranks (normality failed) results: medians [25%, 75%], and p-value for the difference between groups.
(b): Linear regression estimates for age: linear regression coefficient ± StdErr (R, p-value: of the test H.
Figure 5Time runs of fragmentation measures estimated for RR-increments obtained from the HTX groups. Blue marks and curves refer to the group of patients free of complications. Red notation is used for HTX patients with complications. The bold curves represent the best linear regression approximation to the group data. This line is dashed if the hypothesis of the zero regression coefficient cannot be rejected. For both lines, R2 correlation coefficients are shown. Points corresponding to the same patient are connected by faded lines.